By Dr. Steve Wong on December 20, 2023
In the demanding landscape of modern healthcare, physicians bear the weight of both clinical responsibilities and the intricate challenges that come with navigating an evolving health-care system. Physician burdens are a leading cause of practitioner stress and a key factor in early practice exits. Finally, this is being more openly discussed and we are even seeing regulatory and funding bodies starting to acknowledge, and sometimes start to address, this critical issue.
By Dr. Shirley Samuel-Haynes on November 21, 2023
I learned that a palliative approach to care and serious illness conversations address and manage patients’ and families’ psychological, practical, social, loss/grief, spiritual, and physical issues like pain and symptom management in line with their goals of care and help prepare for eventual life closure. Here are practical tips on how to implement this in your practice.
By Beata Chami on November 8, 2023
Experience of imposter feelings is linked to poor mental health outcomes such as anxiety, depression, and burnout and results in lower professional fulfillment. There may not be a “cure” for imposter syndrome, but there are strategies available to minimize the onset of it. Addressing symptoms that can have a significant impact on your well-being and those that you care for.
By Dr. Rachel Grimminck, Dr. Jo Hoffman, and Dr. Laura McLean on October 25, 2023
Given the rapidly shifting social, political, and legal contexts surrounding the use of psychedelics, we realized the need to offer an informed opinion on the use of psychedelics in the same way we offer information and harm reduction strategies for substances such as opiates, cannabis, and alcohol.
By Dr. Nawaaz Nathoo and Sorayya Seddigh on October 11, 2023
There are currently no eye drops for presbyopia treatment that have been approved for use in Canada. In December 2021, pilocarpine hydrochloride 1.25% eye drops became the first drug approved by the FDA for the medical management of presbyopia. Pilocarpine is a miotic agent that uses the eyes’ natural ability to constrict the pupil via parasympathetic innervation. It has been shown to improve near-intermediate vision without impacting distance vision.
By Drs. Jill Norris and Jessica Otte on September 12, 2023
Primary care clinicians face an overwhelming volume of information to process and tasks to complete. There are new and sometimes conflicting guidelines and practice standards, forms to fill out, emails about meetings, and an inbox full of labs, documents to review, and messages to respond to. Now that I get Portraits in my email inbox from time to time, I schedule time to look at them, and focus on the listed recommendations and whether my pattern of practice is close to where it should be according to the evidence, and if not, why not.
By Drs. Domnick Manhas and Tony Wan on August 23, 2023
It is estimated that 15% of all cancer patients will develop VTE, resulting in significant morbidity and mortality. The cost of cancer-associated thrombosis is substantial to the healthcare system. Currently, routine thromboprophylaxis is not recommended given the fear of increased risk of bleeding, modest absolute risk reduction in VTE, and inconvenience. However, a selected group of cancer patients with very high VTE risk will benefit from thromboprophylaxis.
By Dr. Sander Veldhuyzen van Zanten on August 9, 2023
Helicobacter pylori (H. pylori) continues to be an important pathogen, associated with peptic ulcer disease, dyspepsia, and gastric cancer. The conventional triple combination of a PPI, clarithromycin, and either amoxicillin or metronidazole is no longer recommended because its success rates have decreased to less than 60%. The recommended first-line therapy is concomitant therapy (PPI, clarithromycin, amoxicillin, and metronidazole) and second-line therapy is bismuth-based therapy (PPI, bismuth, metronidazole, and tetracycline).
By Vinicio Delgado and Dr. Wayne Lai on July 19, 2023
Insomnia is one of the most commonly reported sleep disorders at our sleep clinic. Despite its prevalence, treating it can be challenging due to its complex and multifactorial nature. A comprehensive and personalized approach to treatment is, therefore, necessary for effective management. However, providing this level of support requires significant time and resources. Offering a self-help intervention as a complement to care can help reach patients who might not otherwise receive CBTi or refuse onsite treatment.
By Hans Haag and Dr. Ricky Turgeon on July 5, 2023
Heart failure is the third leading cause of hospitalization in Canada and leads to readmission in 1 in 5 patients within 30 days after discharge. Iron deficiency (with or without anemia) is an important comorbidity in patients with HF and is associated with worse outcomes. Assess iron deficiency for all patients with HFrEF and HFmrEF admitted for acute HF.
By Jamison Falk, PharmD on June 19, 2023
While I’ve been hard on newer medications like SGLT2i for their relatively small benefit in lower-risk patients, recent systematic reviews show that our traditional interventions are no better, and may be worse, at reducing risks of outcomes. I now discuss the option of adding an SGLT2i with patients with diabetes and pre-existing cardiovascular or renal disease or with symptomatic hyperglycemia where blood glucose reduction would be expected to reduce day-to-day symptoms. I reduce or discontinue doses of other antihyperglycemic medications if possible when starting an SGLT2i and I educate patients about potential adverse events.
By Drs. Kevin Lee and Persia Pourshahnazari on May 31, 2023
While not a fundamentally dangerous condition, CSU can have a significant impact on a patient’s quality of life and can be challenging to manage. Symptoms can be prolonged and can recur even after a long symptom-free period. Escalate and taper non-sedating H1-antihistamines, encourage daily antihistamine use, and add corticosteroids or refer to an allergist if needed.
By Drs. Rohit Vijh and Jason Wong on May 17, 2023
Pregnant persons should be screened for syphilis during the first trimester (or first prenatal visit), and at delivery (or any time after week 35 for those planning home births).
By Drs. Kerstin Gustafson and Colleen Dy on May 2, 2023
Women should be proactively educated at routine visits on menopause and the changes in the genital tract and anyone with vulvar and vaginal complaints should be offered a clinical exam to rule out secondary causes. GSM often continues to worsen with time if untreated. Daily use of vulvar and vaginal moisturizers and barrier creams to protect the skin from irritants may be helpful. Use of lubricants for intercourse should be recommended routinely. Many women will require pharmacotherapy in addition to non-hormonal treatments.
By Dr. Mark Adrian on April 19, 2023
Degenerative lumbar spinal stenosis refers to the narrowing of the spinal canal that can result in numbness, pain, and weakness of the lower extremities. Atypical presentations are common as are competing diagnoses. Top practice tips: distinguish the source of the symptoms, rule out competing disorders, send for imaging, encourage exercises that place the patient in a flexed position, and consider gabapentin, epidural steroid injections, and a referral for a surgical opinion.
By Dr. Emma Coffey on April 3, 2023
Many patients don’t know that an IUD is a highly effective option for emergency contraception. We can offer patients either the 52mg LNG-IUS (up to 5 days) or the copper IUD (up to 7 days) for EC. Both options are highly effective at preventing pregnancy (>99%).
By Drs. Kevin Lee and Persia Pourshahnazari on March 21, 2023
Despite being a fairly common problem, with an estimated prevalence of 0.5–5%, chronic spontaneous urticaria (CSU) is often a challenging condition for health-care providers to diagnose and for patients to accept as a diagnosis. A diagnosis of CSU does not equate to a diagnosis of a systemic autoimmune disease. We do not routinely recommend dietary modification for CSU. We advise patients with CSU to limit alcohol intake and to take a higher dose of antihistamines prior to receiving vaccinations.
By Drs. Clara Lu and Renée Janssen on March 7, 2023
Since the publication of the 2020 ATS Clinical Practice Guideline on pharmacologic treatment in tobacco-dependent adults, I now explain the goals of pharmacotherapy for tobacco use disorder in terms of reducing the compulsion to smoke and increasing readiness to quit, rather than abstinence alone. If patients are open to the conversation, I will discuss and offer all pharmacotherapy options — but emphasize the efficacy and safety of varenicline as my preferred first-line agent.
By Dr. John van Bockxmeer, Dr. Vishal Varshney, and Anthony Lau, PharmD on February 15, 2023
I incorporate this ‘NSAID ceiling’ into my prescribing practice for anti-inflammatory medications. I typically prescribe maximum doses of 400 mg oral ibuprofen TID with meals and 10 mg intramuscular ketorolac. I counsel my patients to limit their NSAID use to a 5-day window when possible and encourage other non-pharmacological and multimodal analgesia.
By Drs. Jennifer Kask and Kirsten Duckitt on January 25, 2023
Preterm birth is the leading cause of perinatal morbidity and mortality in British Columbia and worldwide. We now carefully elicit any history of previous preterm birth and offer vaginal progesterone therapy for ANY history of spontaneous preterm birth. We fill in the Special Authority Request and give out the patient handout even before the patient goes to the pharmacy. We also encourage women to continue the medications until 37 weeks of gestational age.
By Dr. Karin Kausky, Dr. Tracy Monk, and Daniela Michel, MPH on January 11, 2023
Antimicrobial resistance is recognized as a top public health threat and is estimated to be directly responsible for 5,400 deaths and $1.4 billion in health care costs in Canada in 2018 which underlines the critical importance of wise prescribing of antibiotics. Every time I prescribe an antibiotic now, I check the Bugs & Drugs guidelines via PathwaysBC.ca.
Recent Comments